Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Poolbeg Pharma Share Price
  4. Poolbeg Pharma Share Regulatory News

Pin to quick picksPoolbeg Pharma Regulatory News (POLB)

Poolbeg Pharma Information

Share Price Information for Poolbeg Pharma (POLB)

Share Price is delayed by 15 minutes
Get Live Data
8.25    1.10 (14.86%)
Bid:
8.00
Ask:
8.50
Spread: 0.50 (6.25%)
Market Cap: £59.93m
POLB Live PriceLast checked at - London Stock Exchange

Intraday Poolbeg Pharma Share Chart

12345
Date   Source Headline
9th Jan 20254:28 pmRNSForm 8.5- Poolbeg Pharma PLC
9th Jan 202511:01 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
9th Jan 20258:53 amRNSForm 8.5 (EPT/NON-RI)
9th Jan 20257:00 amRNSHolding(s) in Company
8th Jan 20253:56 pmRNSForm 8.5 (EPT/NON-RI) - Poolbeg Pharma PLC
8th Jan 20253:53 pmRNSForm 8 (OPD) - Poolbeg Pharma plc
8th Jan 202510:51 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
8th Jan 20259:44 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 202510:54 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
7th Jan 202510:48 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 20257:00 amRNSUpdate Potential Combination of Poolbeg & HOOKIPA
6th Jan 202510:27 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 202510:19 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
3rd Jan 202511:40 amRNSForm 8.5 (EPT/NON-RI)
3rd Jan 202511:34 amGNWForm 8.5 (EPT/RI) - Poolbeg Pharma Plc
2nd Jan 20257:00 amRNSCombination of Poolbeg and HOOKIPA Pharma Inc.
20th Nov 20247:00 amRNSPOLB 001 Patent Granted in United States
18th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
12th Aug 20241:28 pmRNSHolding(s) in Company
26th Jul 20247:00 amRNSVoluntary Delisting from OTCQB Market
10th Jul 20247:00 amRNSNotification of Major Holdings
2nd Jul 20247:00 amRNSChange of Registered Address
17th Jun 20248:38 amRNSResult of AGM
9th May 20247:00 amRNSAnnual Report & AGM Notice
1st May 20247:00 amRNSSignificant POLB 001 Patent Granted in USA
30th Apr 20247:02 amRNSAppointment of Joint Broker
30th Apr 20247:01 amRNSOption Agreement to Acquire Orphan Drug Candidate
30th Apr 20247:00 amRNSResults for the year ended 31 December 2023
29th Apr 20247:00 amRNSTR-1: Notification of major holdings
22nd Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 20241:42 pmRNSDirector Share Purchase
15th Feb 20247:00 amRNSBoard Role Change and Launch of EIP
17th Jan 20247:00 amRNSFurther data shows POLB001 potential in cancer CRS
20th Dec 20237:00 amRNSRSV AI Drug Candidate Analysis Update
11th Dec 20237:00 amRNSPOLB 001 Data Presented at ASH
30th Nov 20237:00 amRNSDirectorate Change
21st Nov 20237:00 amRNSImmunomodulator II patent granted in Japan
16th Nov 20237:00 amRNSPOLB 001 LPS Trial Data to be Presented at IUIS
9th Nov 20237:00 amRNSFormer Amryt Pharma Leadership Team join Poolbeg
3rd Nov 20237:05 amRNSPOLB001 Data to be Presented at ASH Annual Meeting
1st Nov 20237:00 amRNSPOLB 001 Oncology Programme Update Meeting
26th Oct 20237:00 amRNSSAB Endorses Influenza Drug Targets
17th Oct 20237:00 amRNSPoolbeg Partners with a Nasdaq-Listed Biopharma
29th Sep 20237:00 amRNSFavourable Conclusion of Patent Opposition
20th Sep 20237:00 amRNSImmunomodulator I Patent Portfolio Strengthened
19th Sep 20237:00 amRNSImmunomodulator I Patent Opposition Withdrawal
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
29th Jun 20237:00 amRNSAI led programme identifies influenza drug targets
22nd Jun 20237:00 amRNSOral Vaccine Programme Moves Forward
24th May 20237:00 amRNSBoard Appointment
12345

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
PEL
PEL.L
LSE
0.00%
ING
Ingenta
LSE
-0.21%
JESC
JESC.L
LSE
0.00%
ASL
Aberforth Smaller Companies Trust Plc
LSE
-0.98%
85VK
Aspire Def.fina
LSE
0.00%
Trending
CPI
Capita
LSE
-8.23%
REE
Altona Rare Earths
LSE
-4.35%
OMI
Orosur Mining
LSE
0.00%
NESF
NextEnergy Solar
LSE
-3.92%
GGP
Greatland Resources
LSE
0.07%